Skip to main content
Account

Table 1 Percentage of cells expressing VLA-2 and VLA-6 on their surface on NP exposure

From: Metallic nanoparticles reduce the migration of human fibroblasts in vitro

Groups

VLA-2 (CD49b)

VLA-6 (CD49f)

AgNPs

CTR

66.03 ± 1.50

22.78 ± 0.84

0.1 μg/mL

54.28 ± 1.14**

20.31 ± 0.42*

1 μg/mL

58.57 ± 1.54*

19.99 ± 0.45*

10 μg/mL

47.69 ± 0.51***

19.82 ± 0.33*

AuNPs

CTR

64.35 ± 1.28

19.56 ± 0.43

0.1 μg/mL

79.17 ± 5.67

17.92 ± 0.37*

1 μg/mL

80.39 ± 0.98***

17.55 ± 0.25*

10 μg/mL

61.67 ± 1.38

17.31 ± 0.26**

  1. CTR: non-treated cells; *p < 0.05; **p < 0.01; *** p < 0.001

Navigation